• Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Eksterne analyser

Prevas: Feedback from ABGSC's Investor Days - ABG

Prevas

Dette er en ekstern analyse og afspejler ikke nødvendigvis vores perspektiv eller værdier

Download analyse (PDF)
* Prioritising profitability, targeting 12% EBITA margin
* Building on the 15+ years of defence expertise
* Disciplined M&A approach, waiting for the right fit

A Nordic technical consulting firm

Last week, we hosted Prevas CEO Magnus Welén at ABGSC's Investor Days. The company is a technical consultancy focused on product and production development, specialised in engineering, defence, life science and energy. Founded in 1985 and listed since 1998, Prevas operates across three main markets: Sweden (~81% of total sales, including Norway and other operations), Finland (~12%) and Denmark (~8%). Defence in particular is the fastest growing segment, up 22% in Q1'26 and now representing ~17% of total sales.

Takeaways from the presentation

We took away three key points from the presentation. 1) The current main priority is not rapid growth but rather restoring profitability towards the 12% EBITA margin target, with the adj. EBITA margin having improved for three consecutive quarters. To get there, the company is continuing to adjust the business towards the demand picture seen today, and more specifically, putting extra focus on higher-margin niches such as EAM. 2) Defence was highlighted as a structurally attractive area, where Prevas has built up security systems, processes and customer understanding over 15 years. We also asked about concentration risk, and management said they are comfortable with the current ~17% exposure of total sales, viewing defence as a structural growth area that is here to stay. 3) On M&A, the tone was disciplined, with management noting that new technologies, customer value and cultural fit all need to be right, so we expect M&A activity to remain limited near-term.

Gradual margin recovery underway

As is well known in the consultancy sector, margins have been weighed down by lower demand, leading to increased competition and pricing pressure. Over time, Prevas has undergone several organisational and structural changes to meet demand, as Mr. Welén also discussed, reflected in the one-offs in Q1'26. The result has been improving margins in recent quarters, with management sounding incrementally more positive than two quarters ago. We agree, seeing a gradual margin recovery continuing in the coming quarters, and expect the company to return to positive organic growth in H2'26.